The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical impact of high-throughput sequencing in patients with advanced cancer: Lessons learned from the Michigan Oncology Sequencing Center.
 
Erin Frances Cobain
No Relationships to Disclose
 
Dan R. Robinson
No Relationships to Disclose
 
Yi-Mi Wu
No Relationships to Disclose
 
Francis P. Worden
Consulting or Advisory Role - Bayer/Onyx
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bayer/Onyx; Bristol-Myers Squibb
 
David C. Smith
Research Funding - Abraxis BioScience (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Oncogenex (Inst); OncoMed (Inst); PSMA Development Company (Inst); Tekmira (Inst); Teva (Inst)
 
Scott Schuetze
Research Funding - AB Science (Inst); Amgen (Inst); Biomed (Inst); CytRx Corporation (Inst); Janssen (Inst)
 
Rashmi Chugh
Research Funding - Biomarin (Inst); Lilly (Inst); MabVax (Inst); Morphotek (Inst); Novartis (Inst)
 
Nithya Ramnath
No Relationships to Disclose
 
Anne F. Schott
Research Funding - Dompé Farmaceutici
Patents, Royalties, Other Intellectual Property - Systems and Methods for Tissue Imaging, 8,185,186, Inventor, Submitted on 04/2008. This is a patent for use of diffusion MRI technology to quantitate response to neoadjuvant breast cancer therapy.
 
Daniel F. Hayes
Stock and Other Ownership Interests - InBiomotion; OncImmune
Honoraria - 3rd UK Breast Cancer Meeting, Londong; Lilly
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca (Inst); Janssen Research & Development (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from licensed technology.; Title: A method for predicting progression free and overall survival at each follow-up timepoint during therapy of metastatic breast cancer patients using circulating tumor cells. Patent no. 05725638.0-1223-US2005008602.; Title: Circulating tumor cell capturing techniques and devices. Original application no. 61/593,092.; Title: Diagnosis and treatment of breast cancer. Original application no. 61/079,642; Revised application no. 61/224,310.
 
Arul M. Chinnaiyan
Consulting or Advisory Role - Paradigm
 
Moshe Talpaz
Consulting or Advisory Role - ARIAD; Novartis; Pfizer
Research Funding - ARIAD (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)